Prognostic value of circulating tumor cells in patients with non-small cell lung cancer: a Meta-analysis

Objective To systematically evaluate the prognostic value of circulating tumor cells (CTCs) in patients with non-small cell lung cancer (NSCLC).Methods We electronically searched CNIK, WanFang Data, CBM, VIP, PubMed, Web of Science, The Cochrane Library, and Embase database for literature regarding...

Full description

Saved in:
Bibliographic Details
Main Authors: Ming-Zhen LI, Shao-Hua HE, Ying-Hui JIN, Cheng CHEN, Si-Yu YAN, Yong-Bo WANG, Huan LIU, Zhi-Qing ZHOU, Han XIAO, Rui-Rui YANG, Li-Ming TAN
Format: Article
Language:zho
Published: Editorial Office of New Medicine 2022-08-01
Series:Yixue xinzhi zazhi
Subjects:
Online Access:https://yxxz.whuznhmedj.com/storage/attach/2208/dmyp4WKzxydm4aKhDBGKKRX4d4pHg7mKjs6mzQGa.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850105453956038656
author Ming-Zhen LI
Shao-Hua HE
Ying-Hui JIN
Cheng CHEN
Si-Yu YAN
Yong-Bo WANG
Huan LIU
Zhi-Qing ZHOU
Han XIAO
Rui-Rui YANG
Li-Ming TAN
author_facet Ming-Zhen LI
Shao-Hua HE
Ying-Hui JIN
Cheng CHEN
Si-Yu YAN
Yong-Bo WANG
Huan LIU
Zhi-Qing ZHOU
Han XIAO
Rui-Rui YANG
Li-Ming TAN
author_sort Ming-Zhen LI
collection DOAJ
description Objective To systematically evaluate the prognostic value of circulating tumor cells (CTCs) in patients with non-small cell lung cancer (NSCLC).Methods We electronically searched CNIK, WanFang Data, CBM, VIP, PubMed, Web of Science, The Cochrane Library, and Embase database for literature regarding detection of baseline levels of CTCs and survival in NSCLC patients from inception to 28 September 2021. After screening for inclusion criteria, data extraction and quality assessment were performed followed by Meta-analysis using the RevMan 5.3 and Stata 15.0 software.Results 19 studies were included in this Meta-analysis with a total of 1,853 NSCLC patients. Meta-analysis revealed that NSCLC patients with high levels of CTCs had poorer progression-free survival (PFS) than those with low levels of CTCs [HR=2.49, 95% CI(1.50, 4.13), P=0.0004], but levels of CTCs had no significant predictive effect on overall survival (OS) [HR=1.18, 95%CI(0.70, 1.99), P=0.54].Conclusions Baseline CTCs levels have a significant predictive effect on PFS in NSCLC patients, but have no significant predictive ability on OS. This is an area which requires further study in the future.
format Article
id doaj-art-2b71ca4b6a654794b7b3ae015b1c5cd4
institution OA Journals
issn 1004-5511
language zho
publishDate 2022-08-01
publisher Editorial Office of New Medicine
record_format Article
series Yixue xinzhi zazhi
spelling doaj-art-2b71ca4b6a654794b7b3ae015b1c5cd42025-08-20T02:39:04ZzhoEditorial Office of New MedicineYixue xinzhi zazhi1004-55112022-08-0132425025910.12173/j.issn.1004-5511.2022030066336Prognostic value of circulating tumor cells in patients with non-small cell lung cancer: a Meta-analysisMing-Zhen LIShao-Hua HEYing-Hui JINCheng CHENSi-Yu YANYong-Bo WANGHuan LIUZhi-Qing ZHOUHan XIAORui-Rui YANGLi-Ming TANObjective To systematically evaluate the prognostic value of circulating tumor cells (CTCs) in patients with non-small cell lung cancer (NSCLC).Methods We electronically searched CNIK, WanFang Data, CBM, VIP, PubMed, Web of Science, The Cochrane Library, and Embase database for literature regarding detection of baseline levels of CTCs and survival in NSCLC patients from inception to 28 September 2021. After screening for inclusion criteria, data extraction and quality assessment were performed followed by Meta-analysis using the RevMan 5.3 and Stata 15.0 software.Results 19 studies were included in this Meta-analysis with a total of 1,853 NSCLC patients. Meta-analysis revealed that NSCLC patients with high levels of CTCs had poorer progression-free survival (PFS) than those with low levels of CTCs [HR=2.49, 95% CI(1.50, 4.13), P=0.0004], but levels of CTCs had no significant predictive effect on overall survival (OS) [HR=1.18, 95%CI(0.70, 1.99), P=0.54].Conclusions Baseline CTCs levels have a significant predictive effect on PFS in NSCLC patients, but have no significant predictive ability on OS. This is an area which requires further study in the future.https://yxxz.whuznhmedj.com/storage/attach/2208/dmyp4WKzxydm4aKhDBGKKRX4d4pHg7mKjs6mzQGa.pdfcirculating tumor cell non-small cell lung cancer prognosis meta-analysis
spellingShingle Ming-Zhen LI
Shao-Hua HE
Ying-Hui JIN
Cheng CHEN
Si-Yu YAN
Yong-Bo WANG
Huan LIU
Zhi-Qing ZHOU
Han XIAO
Rui-Rui YANG
Li-Ming TAN
Prognostic value of circulating tumor cells in patients with non-small cell lung cancer: a Meta-analysis
Yixue xinzhi zazhi
circulating tumor cell
non-small cell lung cancer
prognosis
meta-analysis
title Prognostic value of circulating tumor cells in patients with non-small cell lung cancer: a Meta-analysis
title_full Prognostic value of circulating tumor cells in patients with non-small cell lung cancer: a Meta-analysis
title_fullStr Prognostic value of circulating tumor cells in patients with non-small cell lung cancer: a Meta-analysis
title_full_unstemmed Prognostic value of circulating tumor cells in patients with non-small cell lung cancer: a Meta-analysis
title_short Prognostic value of circulating tumor cells in patients with non-small cell lung cancer: a Meta-analysis
title_sort prognostic value of circulating tumor cells in patients with non small cell lung cancer a meta analysis
topic circulating tumor cell
non-small cell lung cancer
prognosis
meta-analysis
url https://yxxz.whuznhmedj.com/storage/attach/2208/dmyp4WKzxydm4aKhDBGKKRX4d4pHg7mKjs6mzQGa.pdf
work_keys_str_mv AT mingzhenli prognosticvalueofcirculatingtumorcellsinpatientswithnonsmallcelllungcancerametaanalysis
AT shaohuahe prognosticvalueofcirculatingtumorcellsinpatientswithnonsmallcelllungcancerametaanalysis
AT yinghuijin prognosticvalueofcirculatingtumorcellsinpatientswithnonsmallcelllungcancerametaanalysis
AT chengchen prognosticvalueofcirculatingtumorcellsinpatientswithnonsmallcelllungcancerametaanalysis
AT siyuyan prognosticvalueofcirculatingtumorcellsinpatientswithnonsmallcelllungcancerametaanalysis
AT yongbowang prognosticvalueofcirculatingtumorcellsinpatientswithnonsmallcelllungcancerametaanalysis
AT huanliu prognosticvalueofcirculatingtumorcellsinpatientswithnonsmallcelllungcancerametaanalysis
AT zhiqingzhou prognosticvalueofcirculatingtumorcellsinpatientswithnonsmallcelllungcancerametaanalysis
AT hanxiao prognosticvalueofcirculatingtumorcellsinpatientswithnonsmallcelllungcancerametaanalysis
AT ruiruiyang prognosticvalueofcirculatingtumorcellsinpatientswithnonsmallcelllungcancerametaanalysis
AT limingtan prognosticvalueofcirculatingtumorcellsinpatientswithnonsmallcelllungcancerametaanalysis